Please assess the completion status of the following clinical trial:

Trial Title: Cerebrolysin REGistry Study in Stroke

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Signed informed consent~* Clinical diagnosis of acute ischemic stroke~* Patient's independence prior to stroke onset (pre-morbid mRS of 0 or 1)~* Reasonable expectation of successful follow-up (max. 100 days)~Exclusion Criteria:~* none

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cerebrolysin group (Type: None): Patients who are treated with Cerebrolysin; dosage, frequency and duration follows local clinical practice in accordance with the terms of the local marketing authorization
- Control group (Type: None): Patients who are not treated with Cerebrolysin; treatment follows local clinical practice

Based on this trial design, predict the completion outcome and termination type (if applicable).